Ocio, Enrique M. http://orcid.org/0000-0002-5765-0085
Perrot, Aurore http://orcid.org/0000-0003-0131-8689
Bories, Pierre
San-Miguel, Jesus F. http://orcid.org/0000-0002-9183-4857
Blau, Igor W.
Karlin, Lionel
Martinez-Lopez, Joaquin
Wang, Song-Yau
Bringhen, Sara http://orcid.org/0000-0003-4539-6363
Marcatti, Magda
Mateos, María-Victoria http://orcid.org/0000-0003-2390-1218
Rodriguez-Otero, Paula http://orcid.org/0000-0001-5236-7785
Oliva, Stefania http://orcid.org/0000-0002-3084-180X
Nogai, Axel
Le Roux, Nadia
Dong, Liyan
Macé, Sandrine
Gassiot, Matthieu
Fitzmaurice, Thomas
Oprea, Corina
Moreau, Philippe http://orcid.org/0000-0003-1780-8746
Funding for this research was provided by:
Sanofi
Article History
Received: 11 November 2022
Revised: 10 May 2023
Accepted: 31 May 2023
First Online: 14 June 2023
Competing interests
: EMO: Honoraria – Amgen, BMS/Celgene, GSK, Janssen, MSD, Oncopeptides, Sanofi, Takeda. AP: Honoraria – AbbVie, Amgen, BMS/Celgene, GSK, Janssen, Sanofi, Takeda. PB: nothing to disclose. JFSM: Honoraria – AbbVie, Amgen, BMS, Celgene, GSK, Haemalogix, Janssen, Karyopharm, MSD, Novartis, Regeneron, Roche, Sanofi, SecuraBio, Takeda. IWB: nothing to disclose. LK: Honoraria – AbbVie, Amgen, Celgene, Janssen, Sanofi, Takeda; Advisory Role: Amgen, Celgene, GSK, Janssen, Takeda. JM-L: Honoraria – Janssen, BMS, Incyte, Roche, Novartis, Amgen, Adaptive, Gilead, Sanofi. WP: nothing to disclose. SB: Honoraria – Janssen, Takeda, Amgen, Sanofi, Celgene, Oncopeptides, GSK, Bristol Myers Squibb. MM: nothing to disclose. M-VM: Honoraria – Sanofi. PR-O: Honoraria – Celgene-BMS, Janssen, Sanofi, AbbVie, GSK, Oncopeptides, Kite Pharma, Amgen. LD, SM, and TF are employed by Sanofi and may hold stock and/or stock options in the company Sanofi. NLR and MG are contractors for Sanofi on behalf of Altran and Excelya. PM: Consulting – AbbVie, Amgen, Celgene, Jansen, Oncopeptides, Sanofi; Honoraria – AbbVie, Amgen, Celgene, Janssen, Oncopeptides, Sanofi; Advisory Role – AbbVie, Amgen, Celgene, Janssen, Oncopeptides, Sanofi.